Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
AZD0780 (Laroprovstat; PCSK9-IN-12; AZD-0780) | CAS 2455427-91-3 ...
AZD0780 | EX-A6975 | PCSK9抑制剂 | TargetMol
AZD0780 | Inhibitor | TargetMol
AZD0780 | PCSK9 inhibitor | CAS 2455427-91-3 | Selleck
Study on the Effects of AZD0780 on Cholesterol Levels in Adults Aged 18 ...
Nuovo farmaco orale AZD0780 riduce del 50% il colesterolo cattivo
AD7380 | PDF | Analog To Digital Converter | Sampling (Signal Processing)
AZD0780 lowers LDL-C in patients on statins: PURSUIT trial | Shahidur ...
AstraZeneca’s AZD0780 Shows Significant LDL Reduction in Phase IIb Trial
Oral Pcsk9 Inhibitor | PDF | Low Density Lipoprotein | Cholesterol
AZD0780
Ad 7780 | PDF | Analog To Digital Converter | Filter (Signal Processing)
An Oral PCSK9 Inhibitor for Treatment of Hypercholesterolemia: The ...
Laroprovstat (AZD0780)
化合物AZD0780 | 2455427-91-3
研究进展 | AZD0780（一种新型口服小分子PCSK9抑制剂）治疗高胆固醇血症的有效性和安全性研究 - 知乎
PCSK9：从“降脂明星”到肝脏靶向疗法“概念验证标准靶点”（附人源化小鼠最新数据） - 知乎
Laroprovstat (AZD0780, AZD-0780) | PCSK9 inhibitor | Probechem Biochemicals
AZD0780; EX-A6975; laroprovstatum; laroprovstat - China Shanghai ...
【速递】口服生物利用度提高，阿斯利康PCSK9小分子加入竞争医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
阿斯利康公布口服PCSK9抑制剂AZD0780的临床数据
阿斯利康口服PCSK9小分子抑制剂AZD0780临床数据亮眼，降低胆固醇水平近80%！
1期临床在他汀基础上使用AZD0780胆固醇降幅达78%——药研快讯
AstraZeneca initiates Phase III clinical trial in China for its oral ...
阿斯利康PCSK9小分子抑制剂AZD0780在华获批临床，针对高血脂人群
Bella Vita Clinical Research | Cape Town
puls | 高コレステロール血症治療における経口PCSK9阻害薬AZD0780の有効性：PURSUITランダム化試験
AZD0780, a novel, oral PCSK9 inhibitor with properties allowing for ...
AZD0780, Novel Oral PCSK9 Inhibitor, Demonstrates Major LDL Cholesterol ...
阿斯利康AZD0780薄膜衣片在中国获批临床 拟用于血脂异常治疗_新浪财经_新浪网
Estudio de enfermedad cardiovascular - CeCim
Abstract 4359604: Model-Based Evaluation of LDL-C Lowering for ...
AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL ...
阿斯利康AZD0780薄膜衣片：中国首获临床许可，挑战血脂异常治疗难题 - 知乎
AstraZeneca’s Phase III Study on AZD0780: A Potential Game-Changer in ...
Novel PCSK9 inhibitor for high cholesterol pass... | MIMS HK
年度十大“明星分子”榜单出炉
ADAU1978WBCPZ_（ADI(亚德诺)/LINEAR）ADAU1978WBCPZ中文资料_价格_PDF手册-立创电子商城
本周国内创新药IND，全球新药NDA、上市获批、III期临床汇总_腾讯新闻
长效降脂疗法，再突破!
破坏抗体表面正电荷分布提高抗体PK表现 - 平头哥
ADE7880ACPZ_（ADI(亚德诺)/LINEAR(凌特)）ADE7880ACPZ中文资料_价格_PDF手册-立创电子商城
laroprovstat-药品详情-NextPharma®数据库-ByDrug-医药魔方数据库
A study to evaluate the Efficacy, Safety, and Pharmacokinetics of ...
